These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9348578

  • 1. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
    Wada H, Tanaka F, Hitomi S.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
    [Abstract] [Full Text] [Related]

  • 2. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
    Wada H, Hitomi S, Teramatsu T.
    J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H.
    J Clin Oncol; 2005 Aug 01; 23(22):4999-5006. PubMed ID: 16051951
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H.
    J Surg Oncol; 2002 Oct 01; 81(2):87-92. PubMed ID: 12355409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y, Tanaka F, Wada H, Hitomi S.
    Gan To Kagaku Ryoho; 1997 Aug 01; 24(10):1245-51. PubMed ID: 9279343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K.
    Gan To Kagaku Ryoho; 1996 Feb 01; 23(3):303-9. PubMed ID: 8712823
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
    Tanaka F, Otake Y, Yanagihara K, Yamada T, Miyahara R, Kawano Y, Li M, Inui K, Wada H.
    Br J Cancer; 2001 Jan 01; 84(2):263-9. PubMed ID: 11161386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
    Ueda H, Sakada T, Kuwahara M, Motohiro A.
    Anticancer Drugs; 2004 Jan 01; 15(1):29-33. PubMed ID: 15090740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan.
    Nakayama T, Noguchi S.
    Oncologist; 2010 Jan 01; 15(1):26-36. PubMed ID: 20080863
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM, Pazdur R, Benner SE, Canetta R.
    Anticancer Drugs; 1998 Jul 01; 9(6):479-90. PubMed ID: 9877235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.